Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
Holding LIXT?
Track your performance easily

Lixte Biotechnology Holdings (LIXT) Income Statement

66 Followers

Lixte Biotechnology Holdings Income Statement

Last quarter (Q ), Lixte Biotechnology Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Lixte Biotechnology Holdings's net income was $-1.01M. See Lixte Biotechnology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
--$ 2.55M$ 3.02M$ 765.09K-
Gross Profit
--$ -2.55M$ -3.02M$ -765.09K-
Operating Expense
$ 2.74M$ 5.09M$ 6.31M$ 6.72M$ 3.27M$ 2.49M
Operating Income
$ -4.67M$ -5.09M$ -6.31M$ -6.72M$ -3.27M$ -2.49M
Net Non Operating Interest Income Expense
$ -8.45K$ -1.25K$ -2.32K$ -7.41K$ -3.67K-
Other Income Expense
$ 7.69K$ 1.95K$ -3.37K$ -626.00$ -4.34K$ -49.72K
Pretax Income
$ -2.35M$ -5.09M$ -6.31M$ -6.73M$ -3.26M$ -2.44M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.34M$ -5.09M$ -6.31M$ -6.73M$ -3.26M$ -2.44M
Basic EPS
$ -2.23$ -2.66$ -4.00---
Diluted EPS
$ -2.23$ -2.66$ -4.00$ -5.00$ -2.90$ -2.40
Basic Average Shares
$ 8.42M$ 1.92M$ 1.58M$ 1.35M$ 1.13M$ 1.12M
Diluted Average Shares
$ 8.42M$ 1.92M$ 1.58M$ 1.35M$ 1.13M$ 1.12M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.74M$ 5.09M$ 6.31M$ 9.74M$ 4.03M$ 2.49M
Net Income From Continuing And Discontinued Operation
$ -4.68M$ -5.09M$ -6.31M$ -6.73M$ -3.26M$ -2.44M
Normalized Income
$ -1.55M$ -3.04M----
Interest Expense
------
EBIT
$ -2.73M$ -5.07M$ -6.30M$ -6.72M$ -3.26M$ -2.44M
EBITDA
$ -2.73M$ -5.07M$ -6.30M$ -6.72M$ -3.26M$ -2.44M
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis